| Multiple Sclerosis |
1 |
1 |
| Disability |
0 |
0.88 |
| Biologic Therapy |
0 |
0.44 |
| Stem Cell Research and Therapy |
0 |
0.35 |
| Europe |
0 |
0.29 |
| Multiple Sclerosis Relapse |
0 |
0.29 |
| Cell Transplantation |
0 |
0.14 |
| Disease-Modifying Therapy |
0 |
0.1 |
| Glatiramer Acetate |
0 |
0.1 |
| Grant |
0 |
0.1 |
| Hospital |
0 |
0.1 |
| Interferon Beta |
0 |
0.1 |
| Monoclonal Antibody |
0 |
0.1 |
| Relapsing Remitting Multiple Sclerosis |
0 |
0.1 |
| Transplantation |
0 |
0.1 |